Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR2 | Q92731 | 4/20 | 0.76 |
| ▸ | ESR1 | P03372 | 3/20 | 0.76 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.51 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.51 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.51 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.49 |
| ▸ | FFAR1 | O14842 | 6/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | ATM | Q13315 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | TAS2R31 | P59538 | 1/20 | 0.46 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.45 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27975607 | 1.00 | ESR2 (0.76) | ESR2ESR1CYP1A1CYP1A2CYP1B1 | |
| SCHEMBL2968481 | 0.92 | ESR1 (0.72) | ESR2ESR1CYP1A1CYP1A2CYP1B1 | |
| SCHEMBL7202314 | 0.89 | ESR1 (0.76) | ESR2ESR1CYP1A1CYP1A2CYP1B1 | |
| Tupichinol C SCHEMBL31060867 | 0.87 | ESR2 (1.00) | ESR2ESR1PTPN1CYP19A1FFAR1 | |
| Tupichinol C SCHEMBL6822846 | 0.87 | ESR2 (1.00) | ESR2ESR1PTPN1CYP19A1FFAR1 | |
| Tupichinol C SCHEMBL2960172 | 0.87 | ESR2 (1.00) | ESR2ESR1PTPN1CYP19A1FFAR1 | |
| Tupichinol C SCHEMBL30205825 | 0.87 | ESR2 (1.00) | ESR2ESR1PTPN1CYP19A1FFAR1 | |
| SCHEMBL16160573 | 0.86 | ESR2 (0.63) | ESR2ESR1PTPN1CYP19A1FFAR1 | |
| SCHEMBL1487483 | 0.83 | ESR2 (0.67) | ESR2ESR1CYP1A1CYP1A2CYP1B1 | |
| SCHEMBL1245170 | 0.83 | ESR2 (0.67) | ESR2ESR1CYP1A1CYP1A2CYP1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250304931-A1 | NOVEL MUTATED LACTONASE ENZYMES, COMPOSITIONS CONTAINING THEM AND USES THEREOF | GENE AND GREEN TK (FR) | 2025-10-02 | — | — | US | claimed |
| EP-4479529-A1 | NOVEL MUTATED LACTONASE ENZYMES, COMPOSITIONS CONTAINING THEM AND USES THEREOF | Gene And Green TK (FR) | 2024-12-25 | — | — | EP | claimed |
| WO-2023156432-A1 | NOVEL MUTATED LACTONASE ENZYMES, COMPOSITIONS CONTAINING THEM AND USES THEREOF | GENE AND GREEN TK (FR) | 2023-08-24 | — | — | WO | claimed |
| US-11234918-B2 | Methods for botanical and/or algae extraction | BASF CORPORATION (US) | 2022-02-01 | — | — | US | claimed |
| US-20250304931-A1 | NOVEL MUTATED LACTONASE ENZYMES, COMPOSITIONS CONTAINING THEM AND USES THEREOF | GENE AND GREEN TK (FR) | 2025-10-02 | — | — | US | disclosed |
| EP-4479529-A1 | NOVEL MUTATED LACTONASE ENZYMES, COMPOSITIONS CONTAINING THEM AND USES THEREOF | Gene And Green TK (FR) | 2024-12-25 | — | — | EP | disclosed |
| US-20240245741-A1 | EXTRACTION METHOD USING AN AQUEOUS ALKANEDIOL | MINASOLVE SAS (FR) | 2024-07-25 | — | — | US | disclosed |
| EP-4401852-A1 | EXTRACTION METHOD USING AN AQUEOUS ALKANEDIOL | Minasolve SAS (FR) | 2024-07-24 | — | — | EP | disclosed |
| CN-117531228-A | Use of coconut water as extraction solvent | 巴斯夫美容护理法国公司 | 2024-02-09 | — | — | CN | disclosed |
| CN-110167527-B | Use of coconut water as extraction solvent | 巴斯夫美容护理法国公司 | 2023-11-17 | — | — | CN | disclosed |
| CN-113315682-B | Method, system and device for generating information transmission performance warning | 动态网络服务股份有限公司 | 2023-09-01 | — | — | CN | disclosed |
| WO-2023156432-A1 | NOVEL MUTATED LACTONASE ENZYMES, COMPOSITIONS CONTAINING THEM AND USES THEREOF | GENE AND GREEN TK (FR) | 2023-08-24 | — | — | WO | disclosed |
| CN-116013534-A | Clinical auxiliary decision-making method and system based on medical guideline and data | 睿愈(南京)数字医疗科技有限公司 | 2023-04-25 | — | — | CN | disclosed |
| CN-115836055-A | Quinazoline compounds, preparation method and application thereof | 益方生物科技(上海)股份有限公司 | 2023-03-21 | — | — | CN | disclosed |
| WO-2023036973-A1 | EXTRACTION METHOD USING AN AQUEOUS ALKANEDIOL | MINASOLVE SAS (FR) | 2023-03-16 | — | — | WO | disclosed |
| US-11234918-B2 | Methods for botanical and/or algae extraction | BASF CORPORATION (US) | 2022-02-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11234918-B2 | Methods for botanical and/or algae extraction | ALG1, ALG8, CUTA | ESR2 4170/4885ESR1 4633/4885CYP1A1 2372/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.